Akèy › Limfom › Iowa › Cedar Rapids

Etid klinik pou Limfom nan Cedar Rapids, IA

6 etid pou Limfom ap chèche patisipan nan sit nan ak bò kote Cedar Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1

University of Iowa Health, Iowa City · 25 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Ap rekriteFaz 2

University of Iowa, Iowa City · 25 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07221500

Collection of Tissue Samples for Cancer Research

Ap rekriteEtid obsèvasyon

University of Iowa, Iowa City · 25 mi lwen

2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Ap rekriteFaz 3

University of Iowa, Iowa City · 25 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06084936

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2

University of Iowa, Iowa City · 25 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3

University of Iowa, Iowa City · 25 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

Etid Limfom nan lòt vil

Lòt etid nan Cedar Rapids

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.